S&P 500 Futures
(0.21%) 4 569.00 points
Dow J Futures
(0.48%) 35 658 points
Nasdaq Futures
(0.25%) 16 064 points
(1.44%) $78.98
(0.39%) $2.82
(0.49%) $2 057.10
(1.29%) $25.40
(-0.06%) 940.80
(0.57%) 0.916
(0.68%) 10.73
(0.45%) 0.791
(0.17%) 88.73

Realtime updates for Oncopeptides AB (publ) [ONCO.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated30 Nov 2023 @ 06:17

-2.27% SEK 8.62

Live Chart Being Loaded With Signals

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally...

Today's Volume 56 039.00
Average Volume 286 133
Market Cap 779.41M
EPS SEK0 ( 2023-11-08 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -3.00
ATR14 SEK0.0560 (0.65%)

Volume Correlation

Long: 0.18 (neutral)
Short: 0.70 (moderate)
Signal:(47.222) Neutral

Oncopeptides AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncopeptides AB (publ) Correlation - Currency/Commodity

The country flag 0.05
( neutral )
The country flag -0.07
( neutral )
The country flag 0.00
( neutral )
The country flag 0.18
( neutral )
The country flag 0.31
( neutral )
The country flag 0.45
( neutral )

Oncopeptides AB (publ) Financials

Annual 2022
Revenue: SEK8.36M
Gross Profit: SEK8.35M (99.93 %)
EPS: SEK-4.11
Q3 2023
Revenue: SEK2.81M
Gross Profit: SEK4.70M (167.59 %)
EPS: SEK-0.450
Q2 2023
Revenue: SEK25.95M
Gross Profit: SEK25.93M (99.90 %)
EPS: SEK-0.620
Q1 2023
Revenue: SEK1.12M
Gross Profit: SEK1.11M (99.02 %)
EPS: SEK-0.790

Oncopeptides AB (publ)

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators